Andreas Tomaschitz

6.5k total citations
80 papers, 2.9k citations indexed

About

Andreas Tomaschitz is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Andreas Tomaschitz has authored 80 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 32 papers in Cardiology and Cardiovascular Medicine and 20 papers in Nephrology. Recurrent topics in Andreas Tomaschitz's work include Hormonal Regulation and Hypertension (32 papers), Blood Pressure and Hypertension Studies (20 papers) and Vitamin D Research Studies (15 papers). Andreas Tomaschitz is often cited by papers focused on Hormonal Regulation and Hypertension (32 papers), Blood Pressure and Hypertension Studies (20 papers) and Vitamin D Research Studies (15 papers). Andreas Tomaschitz collaborates with scholars based in Austria, Germany and Netherlands. Andreas Tomaschitz's co-authors include Stefan Pilz, Winfried März, Eberhard Ritz, Christiane Drechsler, Andreas Meinitzer, Tanja B. Grammer, Nicolas Verheyen, Burkert Pieske, Marcus E. Kleber and Martin Grübler and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Andreas Tomaschitz

78 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Tomaschitz Austria 33 873 859 722 616 554 80 2.9k
Tanja B. Grammer Germany 36 845 1.0× 906 1.1× 684 0.9× 784 1.3× 936 1.7× 110 3.7k
Tayfun Eyıleten Türkiye 33 409 0.5× 869 1.0× 1.1k 1.6× 243 0.4× 504 0.9× 71 3.1k
Naro Ohashi Japan 34 1.0k 1.2× 1.4k 1.6× 1.1k 1.5× 236 0.4× 269 0.5× 119 3.3k
Takefumi Mori Japan 31 804 0.9× 1.0k 1.2× 763 1.1× 160 0.3× 243 0.4× 113 2.8k
Jorge E. Toblli Argentina 36 721 0.8× 1.0k 1.2× 435 0.6× 178 0.3× 278 0.5× 125 3.5k
Chagriya Kitiyakara Thailand 23 347 0.4× 546 0.6× 1.2k 1.7× 286 0.5× 220 0.4× 84 2.7k
Sang Youb Han South Korea 33 718 0.8× 545 0.6× 916 1.3× 147 0.2× 541 1.0× 115 3.3k
Giacomo Deferrari Italy 40 1.1k 1.3× 2.1k 2.5× 2.3k 3.2× 384 0.6× 575 1.0× 160 5.4k
Peter Hovind Denmark 37 1.4k 1.7× 1.0k 1.2× 1.7k 2.4× 393 0.6× 573 1.0× 72 4.2k
Gerjan Navis Netherlands 26 586 0.7× 438 0.5× 693 1.0× 140 0.2× 303 0.5× 79 2.5k

Countries citing papers authored by Andreas Tomaschitz

Since Specialization
Citations

This map shows the geographic impact of Andreas Tomaschitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Tomaschitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Tomaschitz more than expected).

Fields of papers citing papers by Andreas Tomaschitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Tomaschitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Tomaschitz. The network helps show where Andreas Tomaschitz may publish in the future.

Co-authorship network of co-authors of Andreas Tomaschitz

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Tomaschitz. A scholar is included among the top collaborators of Andreas Tomaschitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Tomaschitz. Andreas Tomaschitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keppel, Martin H., Grzegorz Piecha, Winfried März, et al.. (2019). The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension. PLoS ONE. 14(2). e0212973–e0212973. 7 indexed citations
2.
Voelkl, Jakob, Rashad Tuffaha, Trang T. D. Luong, et al.. (2018). Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB. Journal of the American Society of Nephrology. 29(6). 1636–1648. 131 indexed citations
3.
Pilz, Stefan, Christian Trummer, Marlene Pandis, et al.. (2018). Vitamin D: Current Guidelines and Future Outlook. Anticancer Research. 38(2). 1145–1151. 44 indexed citations
4.
Verheyen, Nicolas, Astrid Fahrleitner‐Pammer, Evgeny Belyavskiy, et al.. (2017). Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial. PLoS ONE. 12(4). e0173799–e0173799. 9 indexed citations
5.
Alesutan, Ioana, Jakob Voelkl, Martina Feger, et al.. (2017). Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells. Scientific Reports. 7(1). 2059–2059. 56 indexed citations
6.
Grübler, Martin, Nicolas Verheyen, Johannes Schmid, et al.. (2016). Abstract 17385: Eplerenon Reduces Qtc Time Intervall in Primary Hyperparathyroidism. Circulation. 1 indexed citations
7.
Drechsler, Christiane, Hege Pihlstrøm, Andreas Meinitzer, et al.. (2015). Homoarginine and Clinical Outcomes in Renal Transplant Recipients. Transplantation. 99(7). 1470–1476. 12 indexed citations
8.
Drechsler, Christiane, Graciela Delgado, Christoph Wanner, et al.. (2015). Galectin-3, Renal Function, and Clinical Outcomes. Journal of the American Society of Nephrology. 26(9). 2213–2221. 115 indexed citations
9.
Tomaschitz, Andreas, Nicolas Verheyen, Martin Gaksch, et al.. (2015). Homoarginine in Patients With Primary Hyperparathyroidism. The American Journal of the Medical Sciences. 349(4). 306–311. 8 indexed citations
10.
Koller, Lorenz, Marcus E. Kleber, Georg Goliasch, et al.. (2014). C-Reactive Protein Predicts Mortality in Patients Referred for Coronary Angiography and Symptoms of Heart Failure With Preserved Ejection Fraction. European Journal of Heart Failure. 16(7). 758–766. 54 indexed citations
11.
Grammer, Tanja B., Marcus E. Kleber, Günther Silbernagel, et al.. (2014). Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study). Atherosclerosis. 236(2). 292–300. 41 indexed citations
12.
Pilz, Stefan, Frank Edelmann, Andreas Meinitzer, et al.. (2014). Associations of Methylarginines and Homoarginine With Diastolic Dysfunction and Cardiovascular Risk Factors in Patients With Preserved Left Ventricular Ejection Fraction. Journal of Cardiac Failure. 20(12). 923–930. 36 indexed citations
13.
Tomaschitz, Andreas, Eberhard Ritz, Burkert Pieske, et al.. (2013). Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism. 63(1). 20–31. 127 indexed citations
14.
Tomaschitz, Andreas, Astrid Fahrleitner‐Pammer, Burkert Pieske, et al.. (2012). Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial. BMC Endocrine Disorders. 12(1). 19–19. 21 indexed citations
15.
Pilz, Stefan, Andreas Meinitzer, Andreas Tomaschitz, et al.. (2012). Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients. Osteoporosis International. 24(1). 377–381. 17 indexed citations
16.
Drechsler, Christiane, Andreas Meinitzer, Stefan Pilz, et al.. (2011). Homoarginine, Heart Failure, and Sudden Cardiac Death in Haemodialysis Patients. European Journal of Heart Failure. 13(8). 852–859. 61 indexed citations
17.
Meinitzer, Andreas, Christiane Drechsler, Andreas Tomaschitz, et al.. (2011). Homoarginin: ein neuer kardiovaskulärer Risikomarker bei Dialysepatienten / Homoarginine: a new cardiovascular risk marker in hemodialysis patients. LaboratoriumsMedizin. 35(3). 153–159. 6 indexed citations
18.
Tomaschitz, Andreas, Stefan Pilz, Eberhard Ritz, et al.. (2010). Association of Plasma Aldosterone With Cardiovascular Mortality in Patients With Low Estimated GFR: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. American Journal of Kidney Diseases. 57(3). 403–414. 36 indexed citations
19.
Tomaschitz, Andreas, Winfried Maerz, Stefan Pilz, et al.. (2010). Aldosterone/Renin Ratio Determines Peripheral and Central Blood Pressure Values Over a Broad Range. Journal of the American College of Cardiology. 55(19). 2171–2180. 43 indexed citations
20.
Pilz, Stefan, Andreas Tomaschitz, Vinzenz Stepan, et al.. (2009). Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism. BMC Endocrine Disorders. 9(1). 11–11. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanja B. Grammer Breakdown of academic impact, for papers by Tayfun Eyıleten Breakdown of academic impact, for papers by Naro Ohashi Breakdown of academic impact, for papers by Takefumi Mori Breakdown of academic impact, for papers by Jorge E. Toblli Breakdown of academic impact, for papers by Chagriya Kitiyakara Breakdown of academic impact, for papers by Sang Youb Han Breakdown of academic impact, for papers by Giacomo Deferrari Breakdown of academic impact, for papers by Peter Hovind Breakdown of academic impact, for papers by Gerjan Navis
Rankless by CCL
2026